Effect of neoadjuvant chemoradiotherapy on pathologic stage and survival in patients with locally advanced esophageal cancer.

被引：0
|
作者：
Gibson, M
Burtness, B
Heath, E
Heitmiller, R
Forastiere, AA
机构：
[1] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Yale Univ, Ctr Canc, New Haven, CT USA
[3] Union Mem Hosp, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4032
引用
收藏
页码：321S / 321S
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant chemoradiotherapy combined with perioperative toripalimab in locally advanced esophageal cancer.
    Xu, Xin
    Sun, Zhiyong
    Zhang, Yao
    Shen, Lei
    Liu, Qiang
    Zhang, Chenpeng
    Wu, Huawei
    Lin, Haiping
    Bai, Yongrui
    Ma, Xiumei
    Ye, Qing
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16065 - E16065
  • [2] Pathologic downstaging with taxane-based neoadjuvant chemotherapy correlates with increased survival in patients with locally advanced esophageal cancer.
    Gibson, MK
    Brock, M
    Montgomery, E
    Herman, J
    Baylin, S
    Heath, E
    Heitmiller, R
    Forastiere, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 317S - 317S
  • [3] Effect of neoadjuvant chemoradiotherapy on perioperative immune function of patients with locally advanced esophageal cancer
    Tan, Jun-Tao
    Yang, Yang
    Mao, Nai-Qun
    Liu, De-Sen
    Huang, Ding-Ming
    Pan, Hong
    Xie, Tong
    Pan, Qi
    Yang, Li
    Zhong, Jian-Hong
    Zuo, Chuan-Tian
    DISEASES OF THE ESOPHAGUS, 2017, 30 (02):
  • [4] Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?
    Babic, B.
    Fuchs, H. F.
    Bruns, C. J.
    CHIRURG, 2020, 91 (05): : 379 - 383
  • [5] Neoadjuvant Chemotherapy or Chemoradiotherapy for Locally Advanced Esophageal Cancer
    Smithers, B. Mark
    Thomson, Iain
    THORACIC SURGERY CLINICS, 2013, 23 (04) : 509 - +
  • [6] PATHOLOGICAL RESPONSE IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN PATIENTS TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER.
    On, J.
    Shim, J.
    MacKay, C.
    Ramsay, G.
    Murray, G.
    Parnaby, C.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : E196 - E197
  • [7] Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal cancer
    Cheng, X.
    Chen, Y.
    Wu, X.
    Hao, D.
    Zhang, Y.
    Li, X.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Usefulness of whole body FDG-PET for the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced resectable esophageal cancer.
    Song, SY
    Kim, JH
    Ryu, JS
    Choi, EK
    Lee, GH
    Kim, SB
    Park, SI
    Song, HY
    Jo, KJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 332S - 332S
  • [9] Effect of combined neoadjuvant chemoradiation on overall survival for patients with locally advanced rectal cancer.
    Sun, Zhifei
    Adam, Mohamed A.
    Kim, Jina
    Hsu, Shiao-Wen D.
    Palta, Manisha
    Czito, Brian G.
    Migaly, John
    Mantyh, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [10] Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer - Analysis of Pattern of Recurrence and Prognostic Factors for Survival
    Hihara, J.
    Hamai, Y.
    Emi, M.
    Aoki, Y.
    Sakogawa, K.
    Miyata, Y.
    Okada, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S447 - S447
12345